The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Multiplex Molecular Diagnostic Market Research Report 2025
Synopsis
Since last few years, research and development of multiplex molecular diagnostics test in clinical microbiology have allowed many laboratories around the world to grow more rapidly and with ease. This has also helped many of these institution to analyze these pathogens directly using multiplex molecular diagnostics in clinical specimens. Above all, recent developments such as approval from USFDA to analyze multiple organisms in single run is helping the market of molecular diagnostic panels to flourish. Using multiplex molecular diagnostics tools, researchers and laboratory personals are able to identify most common laboratory pathogens in gastrointestinal and respiratory more effectively. The w respiratory viral, gastrointestinal, or central nervous system infections.
The global Multiplex Molecular Diagnostic market was valued at US$ 5362 million in 2023 and is anticipated to reach US$ 8522.7 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Multiplex Molecular Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multiplex Molecular Diagnostic.
Report Scope
The Multiplex Molecular Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Multiplex Molecular Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multiplex Molecular Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
bioMérieux
SpeeDx
Roche
Contextual Genomics
GenMark Diagnostics
Hologic
Luminex Corporation
Binx Health
Segment by Type
Real-time PCR
Nested PCR with Melt Curve Analysis
PCR with Low density Microarray
PCR with Liquid Phase Bead Array
PCR with Electrochemical Detection
Segment by Application
Clinical Research Laboratory
Hospitals
Academic and Research Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Multiplex Molecular Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Since last few years, research and development of multiplex molecular diagnostics test in clinical microbiology have allowed many laboratories around the world to grow more rapidly and with ease. This has also helped many of these institution to analyze these pathogens directly using multiplex molecular diagnostics in clinical specimens. Above all, recent developments such as approval from USFDA to analyze multiple organisms in single run is helping the market of molecular diagnostic panels to flourish. Using multiplex molecular diagnostics tools, researchers and laboratory personals are able to identify most common laboratory pathogens in gastrointestinal and respiratory more effectively. The w respiratory viral, gastrointestinal, or central nervous system infections.
The global Multiplex Molecular Diagnostic market was valued at US$ 5362 million in 2023 and is anticipated to reach US$ 8522.7 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Multiplex Molecular Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multiplex Molecular Diagnostic.
Report Scope
The Multiplex Molecular Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Multiplex Molecular Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multiplex Molecular Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
bioMérieux
SpeeDx
Roche
Contextual Genomics
GenMark Diagnostics
Hologic
Luminex Corporation
Binx Health
Segment by Type
Real-time PCR
Nested PCR with Melt Curve Analysis
PCR with Low density Microarray
PCR with Liquid Phase Bead Array
PCR with Electrochemical Detection
Segment by Application
Clinical Research Laboratory
Hospitals
Academic and Research Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Multiplex Molecular Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiplex Molecular Diagnostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Real-time PCR
1.2.3 Nested PCR with Melt Curve Analysis
1.2.4 PCR with Low density Microarray
1.2.5 PCR with Liquid Phase Bead Array
1.2.6 PCR with Electrochemical Detection
1.3 Market by Application
1.3.1 Global Multiplex Molecular Diagnostic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical Research Laboratory
1.3.3 Hospitals
1.3.4 Academic and Research Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Multiplex Molecular Diagnostic Market Perspective (2019-2030)
2.2 Multiplex Molecular Diagnostic Growth Trends by Region
2.2.1 Global Multiplex Molecular Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Multiplex Molecular Diagnostic Historic Market Size by Region (2019-2024)
2.2.3 Multiplex Molecular Diagnostic Forecasted Market Size by Region (2025-2030)
2.3 Multiplex Molecular Diagnostic Market Dynamics
2.3.1 Multiplex Molecular Diagnostic Industry Trends
2.3.2 Multiplex Molecular Diagnostic Market Drivers
2.3.3 Multiplex Molecular Diagnostic Market Challenges
2.3.4 Multiplex Molecular Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multiplex Molecular Diagnostic Players by Revenue
3.1.1 Global Top Multiplex Molecular Diagnostic Players by Revenue (2019-2024)
3.1.2 Global Multiplex Molecular Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global Multiplex Molecular Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Multiplex Molecular Diagnostic Revenue
3.4 Global Multiplex Molecular Diagnostic Market Concentration Ratio
3.4.1 Global Multiplex Molecular Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiplex Molecular Diagnostic Revenue in 2023
3.5 Multiplex Molecular Diagnostic Key Players Head office and Area Served
3.6 Key Players Multiplex Molecular Diagnostic Product Solution and Service
3.7 Date of Enter into Multiplex Molecular Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Multiplex Molecular Diagnostic Breakdown Data by Type
4.1 Global Multiplex Molecular Diagnostic Historic Market Size by Type (2019-2024)
4.2 Global Multiplex Molecular Diagnostic Forecasted Market Size by Type (2025-2030)
5 Multiplex Molecular Diagnostic Breakdown Data by Application
5.1 Global Multiplex Molecular Diagnostic Historic Market Size by Application (2019-2024)
5.2 Global Multiplex Molecular Diagnostic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Multiplex Molecular Diagnostic Market Size (2019-2030)
6.2 North America Multiplex Molecular Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Multiplex Molecular Diagnostic Market Size by Country (2019-2024)
6.4 North America Multiplex Molecular Diagnostic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Multiplex Molecular Diagnostic Market Size (2019-2030)
7.2 Europe Multiplex Molecular Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Multiplex Molecular Diagnostic Market Size by Country (2019-2024)
7.4 Europe Multiplex Molecular Diagnostic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Multiplex Molecular Diagnostic Market Size (2019-2030)
8.2 Asia-Pacific Multiplex Molecular Diagnostic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Multiplex Molecular Diagnostic Market Size by Region (2019-2024)
8.4 Asia-Pacific Multiplex Molecular Diagnostic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Multiplex Molecular Diagnostic Market Size (2019-2030)
9.2 Latin America Multiplex Molecular Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Multiplex Molecular Diagnostic Market Size by Country (2019-2024)
9.4 Latin America Multiplex Molecular Diagnostic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multiplex Molecular Diagnostic Market Size (2019-2030)
10.2 Middle East & Africa Multiplex Molecular Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Multiplex Molecular Diagnostic Market Size by Country (2019-2024)
10.4 Middle East & Africa Multiplex Molecular Diagnostic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Detail
11.1.2 BD Business Overview
11.1.3 BD Multiplex Molecular Diagnostic Introduction
11.1.4 BD Revenue in Multiplex Molecular Diagnostic Business (2019-2024)
11.1.5 BD Recent Development
11.2 bioMérieux
11.2.1 bioMérieux Company Detail
11.2.2 bioMérieux Business Overview
11.2.3 bioMérieux Multiplex Molecular Diagnostic Introduction
11.2.4 bioMérieux Revenue in Multiplex Molecular Diagnostic Business (2019-2024)
11.2.5 bioMérieux Recent Development
11.3 SpeeDx
11.3.1 SpeeDx Company Detail
11.3.2 SpeeDx Business Overview
11.3.3 SpeeDx Multiplex Molecular Diagnostic Introduction
11.3.4 SpeeDx Revenue in Multiplex Molecular Diagnostic Business (2019-2024)
11.3.5 SpeeDx Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Multiplex Molecular Diagnostic Introduction
11.4.4 Roche Revenue in Multiplex Molecular Diagnostic Business (2019-2024)
11.4.5 Roche Recent Development
11.5 Contextual Genomics
11.5.1 Contextual Genomics Company Detail
11.5.2 Contextual Genomics Business Overview
11.5.3 Contextual Genomics Multiplex Molecular Diagnostic Introduction
11.5.4 Contextual Genomics Revenue in Multiplex Molecular Diagnostic Business (2019-2024)
11.5.5 Contextual Genomics Recent Development
11.6 GenMark Diagnostics
11.6.1 GenMark Diagnostics Company Detail
11.6.2 GenMark Diagnostics Business Overview
11.6.3 GenMark Diagnostics Multiplex Molecular Diagnostic Introduction
11.6.4 GenMark Diagnostics Revenue in Multiplex Molecular Diagnostic Business (2019-2024)
11.6.5 GenMark Diagnostics Recent Development
11.7 Hologic
11.7.1 Hologic Company Detail
11.7.2 Hologic Business Overview
11.7.3 Hologic Multiplex Molecular Diagnostic Introduction
11.7.4 Hologic Revenue in Multiplex Molecular Diagnostic Business (2019-2024)
11.7.5 Hologic Recent Development
11.8 Luminex Corporation
11.8.1 Luminex Corporation Company Detail
11.8.2 Luminex Corporation Business Overview
11.8.3 Luminex Corporation Multiplex Molecular Diagnostic Introduction
11.8.4 Luminex Corporation Revenue in Multiplex Molecular Diagnostic Business (2019-2024)
11.8.5 Luminex Corporation Recent Development
11.9 Binx Health
11.9.1 Binx Health Company Detail
11.9.2 Binx Health Business Overview
11.9.3 Binx Health Multiplex Molecular Diagnostic Introduction
11.9.4 Binx Health Revenue in Multiplex Molecular Diagnostic Business (2019-2024)
11.9.5 Binx Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Multiplex Molecular Diagnostic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Real-time PCR
Table 3. Key Players of Nested PCR with Melt Curve Analysis
Table 4. Key Players of PCR with Low density Microarray
Table 5. Key Players of PCR with Liquid Phase Bead Array
Table 6. Key Players of PCR with Electrochemical Detection
Table 7. Global Multiplex Molecular Diagnostic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Multiplex Molecular Diagnostic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Multiplex Molecular Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Multiplex Molecular Diagnostic Market Share by Region (2019-2024)
Table 11. Global Multiplex Molecular Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Multiplex Molecular Diagnostic Market Share by Region (2025-2030)
Table 13. Multiplex Molecular Diagnostic Market Trends
Table 14. Multiplex Molecular Diagnostic Market Drivers
Table 15. Multiplex Molecular Diagnostic Market Challenges
Table 16. Multiplex Molecular Diagnostic Market Restraints
Table 17. Global Multiplex Molecular Diagnostic Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Multiplex Molecular Diagnostic Market Share by Players (2019-2024)
Table 19. Global Top Multiplex Molecular Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiplex Molecular Diagnostic as of 2023)
Table 20. Ranking of Global Top Multiplex Molecular Diagnostic Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Multiplex Molecular Diagnostic Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Multiplex Molecular Diagnostic Product Solution and Service
Table 24. Date of Enter into Multiplex Molecular Diagnostic Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Multiplex Molecular Diagnostic Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Multiplex Molecular Diagnostic Revenue Market Share by Type (2019-2024)
Table 28. Global Multiplex Molecular Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Multiplex Molecular Diagnostic Revenue Market Share by Type (2025-2030)
Table 30. Global Multiplex Molecular Diagnostic Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Multiplex Molecular Diagnostic Revenue Market Share by Application (2019-2024)
Table 32. Global Multiplex Molecular Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Multiplex Molecular Diagnostic Revenue Market Share by Application (2025-2030)
Table 34. North America Multiplex Molecular Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Multiplex Molecular Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Multiplex Molecular Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Multiplex Molecular Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Multiplex Molecular Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Multiplex Molecular Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Multiplex Molecular Diagnostic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Multiplex Molecular Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Multiplex Molecular Diagnostic Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Multiplex Molecular Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Multiplex Molecular Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Multiplex Molecular Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Multiplex Molecular Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Multiplex Molecular Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Multiplex Molecular Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 49. BD Company Detail
Table 50. BD Business Overview
Table 51. BD Multiplex Molecular Diagnostic Product
Table 52. BD Revenue in Multiplex Molecular Diagnostic Business (2019-2024) & (US$ Million)
Table 53. BD Recent Development
Table 54. bioMérieux Company Detail
Table 55. bioMérieux Business Overview
Table 56. bioMérieux Multiplex Molecular Diagnostic Product
Table 57. bioMérieux Revenue in Multiplex Molecular Diagnostic Business (2019-2024) & (US$ Million)
Table 58. bioMérieux Recent Development
Table 59. SpeeDx Company Detail
Table 60. SpeeDx Business Overview
Table 61. SpeeDx Multiplex Molecular Diagnostic Product
Table 62. SpeeDx Revenue in Multiplex Molecular Diagnostic Business (2019-2024) & (US$ Million)
Table 63. SpeeDx Recent Development
Table 64. Roche Company Detail
Table 65. Roche Business Overview
Table 66. Roche Multiplex Molecular Diagnostic Product
Table 67. Roche Revenue in Multiplex Molecular Diagnostic Business (2019-2024) & (US$ Million)
Table 68. Roche Recent Development
Table 69. Contextual Genomics Company Detail
Table 70. Contextual Genomics Business Overview
Table 71. Contextual Genomics Multiplex Molecular Diagnostic Product
Table 72. Contextual Genomics Revenue in Multiplex Molecular Diagnostic Business (2019-2024) & (US$ Million)
Table 73. Contextual Genomics Recent Development
Table 74. GenMark Diagnostics Company Detail
Table 75. GenMark Diagnostics Business Overview
Table 76. GenMark Diagnostics Multiplex Molecular Diagnostic Product
Table 77. GenMark Diagnostics Revenue in Multiplex Molecular Diagnostic Business (2019-2024) & (US$ Million)
Table 78. GenMark Diagnostics Recent Development
Table 79. Hologic Company Detail
Table 80. Hologic Business Overview
Table 81. Hologic Multiplex Molecular Diagnostic Product
Table 82. Hologic Revenue in Multiplex Molecular Diagnostic Business (2019-2024) & (US$ Million)
Table 83. Hologic Recent Development
Table 84. Luminex Corporation Company Detail
Table 85. Luminex Corporation Business Overview
Table 86. Luminex Corporation Multiplex Molecular Diagnostic Product
Table 87. Luminex Corporation Revenue in Multiplex Molecular Diagnostic Business (2019-2024) & (US$ Million)
Table 88. Luminex Corporation Recent Development
Table 89. Binx Health Company Detail
Table 90. Binx Health Business Overview
Table 91. Binx Health Multiplex Molecular Diagnostic Product
Table 92. Binx Health Revenue in Multiplex Molecular Diagnostic Business (2019-2024) & (US$ Million)
Table 93. Binx Health Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiplex Molecular Diagnostic Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Multiplex Molecular Diagnostic Market Share by Type: 2023 VS 2030
Figure 3. Real-time PCR Features
Figure 4. Nested PCR with Melt Curve Analysis Features
Figure 5. PCR with Low density Microarray Features
Figure 6. PCR with Liquid Phase Bead Array Features
Figure 7. PCR with Electrochemical Detection Features
Figure 8. Global Multiplex Molecular Diagnostic Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Multiplex Molecular Diagnostic Market Share by Application: 2023 VS 2030
Figure 10. Clinical Research Laboratory Case Studies
Figure 11. Hospitals Case Studies
Figure 12. Academic and Research Centers Case Studies
Figure 13. Others Case Studies
Figure 14. Multiplex Molecular Diagnostic Report Years Considered
Figure 15. Global Multiplex Molecular Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Multiplex Molecular Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Multiplex Molecular Diagnostic Market Share by Region: 2023 VS 2030
Figure 18. Global Multiplex Molecular Diagnostic Market Share by Players in 2023
Figure 19. Global Top Multiplex Molecular Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiplex Molecular Diagnostic as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Multiplex Molecular Diagnostic Revenue in 2023
Figure 21. North America Multiplex Molecular Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Multiplex Molecular Diagnostic Market Share by Country (2019-2030)
Figure 23. United States Multiplex Molecular Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Multiplex Molecular Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Multiplex Molecular Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Multiplex Molecular Diagnostic Market Share by Country (2019-2030)
Figure 27. Germany Multiplex Molecular Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Multiplex Molecular Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Multiplex Molecular Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Multiplex Molecular Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Multiplex Molecular Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Multiplex Molecular Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Multiplex Molecular Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Multiplex Molecular Diagnostic Market Share by Region (2019-2030)
Figure 35. China Multiplex Molecular Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Multiplex Molecular Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Multiplex Molecular Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Multiplex Molecular Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Multiplex Molecular Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Multiplex Molecular Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Multiplex Molecular Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Multiplex Molecular Diagnostic Market Share by Country (2019-2030)
Figure 43. Mexico Multiplex Molecular Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Multiplex Molecular Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Multiplex Molecular Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Multiplex Molecular Diagnostic Market Share by Country (2019-2030)
Figure 47. Turkey Multiplex Molecular Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Multiplex Molecular Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. BD Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2019-2024)
Figure 50. bioMérieux Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2019-2024)
Figure 51. SpeeDx Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2019-2024)
Figure 52. Roche Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2019-2024)
Figure 53. Contextual Genomics Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2019-2024)
Figure 54. GenMark Diagnostics Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2019-2024)
Figure 55. Hologic Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2019-2024)
Figure 56. Luminex Corporation Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2019-2024)
Figure 57. Binx Health Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
